Mirvetuximab-MMAE
Mirvetuximab-MMAE is an ADC targeting FOLR1 (folate receptor 1). It can be used in ovarian and other FRĪ±-positive cancer research. MW :145.96 KD.
| Catalog Number | D4060 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/anti-folr1-mirvetuximab-mmae.html |